The American Cancer Society is proud to be the beneficiary of a new partnership with Novartis and the National Football League (NFL), strengthening the impact of the league’s Crucial Catch initiative. #CrucialCatch is dedicated to raising awareness about cancer prevention, early detection, and risk reduction. Through this collaboration, Novartis will join ACS and the NFL in their commitment to help more people detect cancer early and reduce disparities in under-resourced communities. This effort is critical, as early detection saves lives. Learn more: nfl.com/crucialcatch
Health is a team sport. 🏈 That’s why we are proud to be the first official corporate pharmaceutical partner of the National Football League (NFL) with the shared goal of bringing innovation and community together to improve health outcomes. 🤝 Too many fans stay on the sidelines when it comes to their health. Through this first-of-its-kind collaboration, we are making preventative health part of the game—helping fans take charge, normalize screenings, and build healthier communities. Join us as we kick off a new era in health awareness. 👍 🔗 Learn more: https://lnkd.in/g4AqNECV
Thank you for sharing
Corporate Relations Director, Local, Regional & National Partnerships, American Cancer Society
2wThank you!